Core Laboratories Inc.
CLB
$13.36
$0.181.33%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.34% | 0.51% | -1.02% | 0.70% | 1.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.34% | 0.51% | -1.02% | 0.70% | 1.32% |
| Cost of Revenue | 1.15% | -0.70% | -0.38% | 2.59% | 3.07% |
| Gross Profit | 2.10% | 5.43% | -3.50% | -6.39% | -5.24% |
| SG&A Expenses | 11.78% | 14.60% | 12.10% | 4.56% | 17.66% |
| Depreciation & Amortization | -0.88% | -2.03% | -3.42% | -4.47% | -4.85% |
| Other Operating Expenses | 56.66% | 28.30% | 38.21% | -37.65% | -244.83% |
| Total Operating Expenses | 2.37% | 0.65% | 0.74% | 2.40% | 3.46% |
| Operating Income | -8.26% | -0.73% | -15.63% | -13.37% | -15.13% |
| Income Before Tax | 0.52% | -0.63% | -3.04% | 5.44% | -1.04% |
| Income Tax Expenses | -4.35% | 10.48% | -37.86% | -22.84% | 169.86% |
| Earnings from Continuing Operations | 2.91% | -5.48% | 20.70% | 24.15% | -24.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 24.22% | 4.12% | 34.16% | 7.19% | -28.13% |
| Net Income | 3.60% | -5.51% | 22.63% | 24.98% | -25.31% |
| EBIT | -8.26% | -0.73% | -15.63% | -13.37% | -15.13% |
| EBITDA | -6.57% | -1.02% | -13.03% | -11.43% | -12.98% |
| EPS Basic | 5.10% | -4.19% | 23.29% | 24.60% | -25.94% |
| Normalized Basic EPS | -8.49% | 3.87% | -16.26% | -12.48% | -18.60% |
| EPS Diluted | 2.91% | -6.18% | 22.46% | 27.27% | -23.99% |
| Normalized Diluted EPS | -8.39% | 4.42% | -16.03% | -12.29% | -18.48% |
| Average Basic Shares Outstanding | -1.44% | -1.11% | -0.43% | 0.04% | 0.32% |
| Average Diluted Shares Outstanding | -1.52% | -1.64% | -0.96% | -0.46% | -0.13% |
| Dividend Per Share | -25.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.04% | 0.05% | -0.19% | -0.20% | 0.34% |